N60.2
Fibroadenosis of breast
Clinical Classification Guidelines
Inclusion Terms
- Adenofibrosis of breast
Excludes Type 2
- fibroadenoma of breast (D24.-)
Medical Intelligence & Overview
Fibroadenosis of the breast, also known as adenofibrosis, is a common benign condition characterized by the presence of benign lumps and changes in the breast tissue. It primarily affects women of reproductive age and involves an abnormal response of breast tissue to hormonal fluctuations. Although it can cause discomfort and changes in the appearance of the breast, it is not linked to breast cancer. Proper understanding and management of fibroadenosis can help alleviate symptoms and reduce anxiety associated with breast health.
Causes & Symptoms
Clinical Causes: Hormonal fluctuations, especially involving estrogen and progesterone Genetic predisposition or family history of benign breast conditions Hormonal therapies or contraceptive use Reproductive history, including pregnancy and breastfeeding Lifestyle factors such as diet and stress that may influence hormonal balance
Key Symptoms: Multiple, round, firm, and rubbery breast lumps that may be tender or painful Breast swelling or thickening, especially before menstruation Breast tenderness or soreness, often cyclical in nature Changes in the breast texture, including areas of increased firmness No significant change in breast size or shape in many cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of fibroadenosis typically involves a combination of clinical examination and imaging tests. The healthcare provider will examine the breasts for lumps, tenderness, and overall breast health. Imaging modalities include:
Treatment Protocols: The management of fibroadenosis focuses on relieving symptoms and monitoring any changes. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is N60.2 a billable ICD-10 code?
Yes, N60.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N60.2?
Clinical documentation must specify the nature of Fibroadenosis of breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference